|
|
Previous Article | Table of Contents | Next Article 
5-Aza-2'-deoxycytidine induces terminal differentiation of leukemic blasts
from patients with acute myeloid leukemias
A Pinto, V Attadia, A Fusco, F Ferrara, OA Spada and PP Di Fiore
In this study, the effects of 5-aza-2'-deoxycytidine on differentiation of
human leukemic cells in primary suspension culture are reported for the
first time. Morphological and functional differentiation was induced in
cells from two acute monoblastic leukemias and two of three acute myeloid
leukemias following repeated exposures to 1 mumol/L 5-aza-
2'-deoxycytidine. The observation that nontoxic concentrations of the drug
are able to induce the in vitro differentiation of both monoblastic and
myeloblastic leukemic cells into mature elements may encourage the
exploitation of the differentiating properties of 5-aza- 2'-deoxycytidine
in chemotherapy protocols for acute non-lymphoblastic leukemias.
Volume 64,
Issue 4,
pp. 922-929,
10/01/1984
Copyright © 1984 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
J. Goffin and E. Eisenhauer
DNA methyltransferase inhibitors--state of the art
Ann. Onc.,
November 1, 2002;
13(11):
1699 - 1716.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Daskalakis, T. T. Nguyen, C. Nguyen, P. Guldberg, G. Kohler, P. Wijermans, P. A. Jones, and M. Lubbert
Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment
Blood,
September 26, 2002;
100(8):
2957 - 2964.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Santini, H. M. Kantarjian, and J.-P. Issa
Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications
Ann Intern Med,
April 3, 2001;
134(7):
573 - 586.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Wijermans, M. Lubbert, G. Verhoef, A. Bosly, C. Ravoet, M. Andre, and A. Ferrant
Low-Dose 5-Aza-2'-Deoxycytidine, a DNA Hypomethylating Agent, for the Treatment of High-Risk Myelodysplastic Syndrome: A Multicenter Phase II Study in Elderly Patients
J. Clin. Oncol.,
March 1, 2000;
18(5):
956 - 956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. T. Ferguson, P. M. Vertino, J. R. Spitzner, S. B. Baylin, M. T. Muller, and N. E. Davidson
Role of Estrogen Receptor Gene Demethylation and DNA Methyltransferase·DNA Adduct Formation in 5-Aza-2'deoxycytidine-induced Cytotoxicity In Human Breast Cancer Cells
J. Biol. Chem.,
December 19, 1997;
272(51):
32260 - 32266.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Gattei, A. Celetti, A. Cerrato, M. Degan, A. De Iuliis, F. M. Rossi, G. Chiappetta, C. Consales, S. Improta, V. Zagonel, et al.
Expression of the RET Receptor Tyrosine Kinase and GDNFR-alpha in Normal and Leukemic Human Hematopoietic Cells and Stromal Cells of the Bone Marrow Microenvironment
Blood,
April 15, 1997;
89(8):
2925 - 2937.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|